Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trilaciclib + Immunotherapy + Chemotherapy in Advanced HNSCC
NCT07679997Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2026
- Primary completion
- Sep 2027
01
Overview
A Phase 2 trial of trilaciclib in head and neck squamous cell carcinoma (HNSCC), sponsored by Sun Yat-sen Memorial Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
trilaciclib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07679997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07679997.